Synonyms: HU-308 | HU308 | LS-193061
Compound class:
Synthetic organic
Comment: HU308 is a synthetic cannabinoid. Its acts as a CB2 receptor agonist and has anti-inflammatory activity. The chemical structure of HU308 matches that for the INN compound onternabez that was surfaced in WHO Proposed list 125 in July 2021.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E. (1999)
HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci USA, 96 (25): 14228-33. [PMID:10588688] |
2. Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW. (2008)
Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. Biochem Pharmacol, 76 (8): 1014-23. [PMID:18755158] |